A strategy to achieve CRT response in permanent atrial fibrillation without obligatory atrioventricular node ablation

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 8, 2012, Pages 943-947

  Himmel, Frank ^a   Reppel, Michael ^a   Mortensen, Kai ^a   Schunkert, Heribert ^a   Bode, Frank ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

atrial fibrillation; atrioventricular node ablation; cardiac resynchronization therapy

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ABLATION THERAPY; ADULT; AGED; ARTICLE; ATRIOVENTRICULAR NODE ABLATION; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; QRS COMPLEX; SINUS RHYTHM; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84864693879     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03433.x     Document Type: Article

References (18)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, et al,. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.
2. Bode F, Schütte F,. [Optimized CRT programming: Relevance and practical application.]. Herzschrittmacherther Elektrophysiol 2009; 20: 121-130.
3. Jeevanantham V, Zareba W, Navaneethan S, Fitzgerald D, Yu CM, Achilli A, Bax J, et al,. Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex. Cardiol J 2008; 15: 230-236.
4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, et al,. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51: e1-62.
5. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, et al,. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-408.
6. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, et al,. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007; 28: 2256-2295.
7. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, et al,. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 2007; 9: 959-998.
8. Daubert JC,. Introduction to atrial fibrillation and heart failure: A mutually noxious association. Europace 2004; 5 (Suppl 1): S1-4.
9. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr., et al,. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace 2007; 9: 335-379.
10. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al,. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
11. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S, McKenna W, et al,. Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002; 40: 111-118.
12. Caldwell JC, Contractor H, Petkar S, Ali R, Clarke B, Garratt CJ, Neyses L, et al,. Atrial fibrillation is under-recognized in chronic heart failure: Insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace 2009; 11: 1295-1300.
13. Khadjooi K, Foley PW, Chalil S, Anthony J, Smith RE, Frenneaux MP, Leyva F,. Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart 2008; 94: 879-883.
14. Hoppe UC,. Resynchronization therapy in the context of atrial fibrillation: Benefits and limitations. J Interv Card Electrophysiol 2007; 18: 225-232.
15. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L,. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
16. Molhoek SG, Bax JJ, Bleeker GB, Boersma E, van Erven L, Steendijk P, van der Wall EE, et al,. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 2004; 94: 1506-1509.
17. Gasparini M, Auricchio A, Regoli F, Fantoni C, Kawabata M, Galimberti P, Pini D, et al,. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: The importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006; 48: 734-743.
18. Patel D, Natale A, Di Biase L, Burkhardt JD, Wang Y, Sanchez JE, Horton RP, et al,. Catheter ablation for atrial fibrillation: A promising therapy for congestive heart failure. Expert Rev Cardiovasc Ther 2009; 7: 779-787.